Decentralized Clinical Trials and Research in Dermatology

There have been significant changes in how the pharmaceutical industry develops medications and conducts clinical trials in dermatology and other medical specialties. Digital health solutions have been vital in adopting patient-centricity in clinical trials.

With increased costs and time to bring new drugs to market, the demand for hybrid or decentralized clinical trials (DCTs) in dermatology has risen.

Decentralized or hybrid clinical trials?are clinical studies with a focus on patient-centricity supported by mobile or digital health technologies to collect patient-reported data and outcomes. They can take place fully remote or hybrid, meaning patients must visit the research facility at least once.??

Hybrid or virtual clinical studies in dermatology are conducted remotely. Patients report data at home or from a suitable location closer to their home virtually and in-home clinical visits

Types of Clinical Trials

There are three clinical trial types, traditional, decentralized, and hybrid. Hybrid or Virtual Dermatology Clinical Trials Meet Patients where they are.

• Fully Centralized (traditional): all clinical study procedures are conducted at the research site
• Hybrid (mixed): Initial registration and complex procedures are conducted at the research site while simple procedures that require in-person visits are conducted at an alternative or mobile site, while simple procedures take place remotely.
• Fully Decentralized (virtual): All trial procedures take place virtually.

Click on the link to continue reading: https://miiskin.com/dermatology/decentralized-clinical-trials-research/